ASTH
Price
$55.90
Change
+$1.43 (+2.63%)
Updated
Sep 16, 03:03 PM (EDT)
45 days until earnings call
USPH
Price
$84.83
Change
+$0.23 (+0.27%)
Updated
Sep 16, 09:36 AM (EDT)
52 days until earnings call
Ad is loading...

ASTH vs USPH

Header iconASTH vs USPH Comparison
Open Charts ASTH vs USPHBanner chart's image
Astrana Health
Price$55.90
Change+$1.43 (+2.63%)
Volume$100
CapitalizationN/A
US Physical Therapy
Price$84.83
Change+$0.23 (+0.27%)
Volume$120
CapitalizationN/A
View a ticker or compare two or three
ASTH vs USPH Comparison Chart
Loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
USPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ASTH vs. USPH commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and USPH is a StrongBuy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (ASTH: $54.47 vs. USPH: $84.59)
Brand notoriety: ASTH and USPH are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ASTH: 174% vs. USPH: 76%
Market capitalization -- ASTH: $1.88B vs. USPH: $1.69B
ASTH [@Medical/Nursing Services] is valued at $1.88B. USPH’s [@Medical/Nursing Services] market capitalization is $1.69B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 0 FA rating(s) are green whileUSPH’s FA Score has 2 green FA rating(s).

  • ASTH’s FA Score: 0 green, 5 red.
  • USPH’s FA Score: 2 green, 3 red.
According to our system of comparison, USPH is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 3 TA indicator(s) are bullish while USPH’s TA Score has 6 bullish TA indicator(s).

  • ASTH’s TA Score: 3 bullish, 4 bearish.
  • USPH’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, USPH is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Medical/Nursing Services) experienced а +14.34% price change this week, while USPH (@Medical/Nursing Services) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -1.89%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

ASTH is expected to report earnings on Oct 31, 2024.

USPH is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Medical/Nursing Services (+0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTH($1.88B) has a higher market cap than USPH($1.69B). USPH has higher P/E ratio than ASTH: USPH (87.62) vs ASTH (32.55). ASTH YTD gains are higher at: 42.219 vs. USPH (-7.926). ASTH has higher annual earnings (EBITDA): 124M vs. USPH (74.4M). ASTH has more cash in the bank: 296M vs. USPH (153M). USPH has less debt than ASTH: USPH (259M) vs ASTH (321M). ASTH has higher revenues than USPH: ASTH (1.39B) vs USPH (605M).
ASTHUSPHASTH / USPH
Capitalization1.88B1.69B111%
EBITDA124M74.4M167%
Gain YTD42.219-7.926-533%
P/E Ratio32.5587.6237%
Revenue1.39B605M229%
Total Cash296M153M193%
Total Debt321M259M124%
FUNDAMENTALS RATINGS
ASTH vs USPH: Fundamental Ratings
ASTH
USPH
OUTLOOK RATING
1..100
7912
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
6686
PRICE GROWTH RATING
1..100
3761
P/E GROWTH RATING
1..100
7114
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

USPH's Valuation (30) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (70) in the null industry. This means that USPH’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Profit vs Risk Rating (59) in the null industry is somewhat better than the same rating for USPH (100) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew somewhat faster than USPH’s over the last 12 months.

ASTH's SMR Rating (66) in the null industry is in the same range as USPH (86) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to USPH’s over the last 12 months.

ASTH's Price Growth Rating (37) in the null industry is in the same range as USPH (61) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to USPH’s over the last 12 months.

USPH's P/E Growth Rating (14) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (71) in the null industry. This means that USPH’s stock grew somewhat faster than ASTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHUSPH
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 13 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
71%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
66%
View a ticker or compare two or three
Ad is loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
USPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSCCX8.980.25
+2.86%
Victory RS Small Cap Equity C
HWACX35.420.36
+1.03%
Hotchkis & Wiley Value Opps C
FEICX35.790.30
+0.85%
Fidelity Advisor Equity Income C
PEIPX42.590.30
+0.71%
Principal Equity Income R4
MEMKX10.31N/A
N/A
BNY Mellon Emerging Markets M

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with PNTG. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then PNTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+5.42%
PNTG - ASTH
44%
Loosely correlated
+3.66%
HCSG - ASTH
43%
Loosely correlated
+5.00%
NHC - ASTH
42%
Loosely correlated
+0.97%
USPH - ASTH
41%
Loosely correlated
+2.09%
ENSG - ASTH
41%
Loosely correlated
+0.54%
More

USPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, USPH has been loosely correlated with SEM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if USPH jumps, then SEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USPH
1D Price
Change %
USPH100%
+2.09%
SEM - USPH
52%
Loosely correlated
+1.64%
SGRY - USPH
49%
Loosely correlated
+3.47%
EHC - USPH
48%
Loosely correlated
+0.70%
ENSG - USPH
46%
Loosely correlated
+0.54%
THC - USPH
43%
Loosely correlated
+2.78%
More